No survival benefit was found for levetiracetam in a meta-analysis by Chen et al.[51▪] but levetiracetam may have a more beneficial effect in unmethylated 0(6)-methylguanine-DNA methyltransferase (MGMT) promotor glioblastoma patients. The gene discussed is MGMT; the disease is glioblastoma.